Sysmed (China) Co., Ltd. was established in November 2000. It is jointly invested by three legal entities, including Shenyang Institute of Automation, Chinese Academy of Sciences, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Shenyang Branch, Chinese Academy of Sciences, and some natural persons and core employees of the company. Among the newly established enterprises, state-owned shares account for 50.16%. Currently, the company's registered capital is 41.8 million yuan.

On June 10, 2014, the company was listed on the National Equities Exchange and Quotations System for Small and Medium-sized Enterprises, stock code: 830803, stock abbreviation: "新松医疗".

Sysmed (China) Co., Ltd. is mainly engaged in the R&D, production and manufacture of medical oxygen concentrators, non-invasive ventilators and other respiratory rehabilitation products, and has gradually become the industry's leading provider of respiratory rehabilitation solutions. The company's products have reached international advanced and domestic leading levels.

Sysmed (China) Co., Ltd. has established a complete quality management system and has successively passed ISO 13485 medical device quality management system certification and JGMP certification, and its products have passed the EU CE certification.